aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Seattle Children's is a Seattle-based hospital specializing in pediatric care. It offers a range of medical and surgical services, including emergency care, women's health, cardiology, orthopedics, and oncology. The hospital is affiliated with the University of Washington School of Medicine and serves patients and healthcare professionals across the United States.
Founded in 1907, Seattle Children's has grown to a 407-bed facility with a dedicated helipad. It has made significant contributions to pediatric healthcare, leveraging its affiliation with the University of Washington for advanced medical research and training. The hospital is recognized for its comprehensive care and specialized services.
Operating Status
Active
Ownership Type(s)
Private
Main Product(s)
Healthcare, Hospital
Technology
Telemedicine
Tags
Healthtech
Model Types
Professional Services
Revenue Type(s)
Transactional
Customer Type(s)
Consumers, Non-Profit
Geographic Exposure
United States
When was Seattle Children's founded?
Seattle Children's was founded in 1907.
Where is Seattle Children's’s headquarters located?
Seattle Children's’s headquarters is located in Seattle, US.
When was Seattle Children's’s last funding round?
Seattle Children's’s most recent funding round was for $200k (USD) in September 2022.
How many employees does Seattle Children's have?
Seattle Children's has 8213 employees as of Feb 5, 2024.
How much has Seattle Children's raised to-date?
As of July 05, 2023, Seattle Children's has raised a total of $200k (USD) since Sep 27, 2022.
Add Comparison
Total Raised to Date
$200k
USD
Last Update Sep 27, 2022
Last Deal Details
$200k
USD
Sep 27, 2022
Grant
Total Employees Over Time
8213
As of Feb 2024
Seattle Children's Address
4800 Sand Point Way NE
Seattle,
98105-3901
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts